Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Common Mistakes in Applying FIFO and FEFO in Practice

Posted on November 25, 2025November 25, 2025 By digi


Common Mistakes in Applying FIFO and FEFO in Practice

Step-by-Step Tutorial on Avoiding Common Mistakes in Applying FIFO and FEFO in Pharmaceutical Warehouses

Effective inventory management is critical in pharmaceutical warehouses to ensure product quality, minimize risks, and comply with regulatory requirements. The principles of FIFO (First-In, First-Out) and FEFO (First-Expired, First-Out) are foundational for managing stock rotation, preventing stock expiry, and avoiding costly mispicks. However, incorrect application of FIFO and FEFO often leads to compliance issues, product recalls, and operational inefficiencies. This comprehensive step-by-step tutorial addresses common mistakes encountered in the implementation of fifo and fefo in pharmaceutical warehouses within the US, UK, and EU regulatory environments. It aims to provide a practical guide for manufacturing, quality assurance (QA), quality control (QC), supply chain management, and regulatory professionals.

Understanding FIFO and FEFO: Definitions and Regulatory Context

Before delving into common mistakes and corrective actions, it is essential to clearly understand what FIFO and FEFO mean in the context of pharmaceutical warehouse management:

  • FIFO (First-In, First-Out) ensures that the oldest inventory received into the warehouse is the first to be dispatched or consumed. This method prioritizes the chronological order of receipt dates to manage stock.
  • FEFO (First-Expired, First-Out) emphasizes the expiration dates of the products and ensures that items with the earliest expiration are issued first, regardless of receipt date.

Both inventory management methods are recognized by global regulatory authorities such as the FDA (21 CFR Part 211), EMA’s EU GMP Volume 4, and PIC/S guidelines, particularly Annex 1 and Annex 15, which emphasize stringent control over expiry and traceability.

The pharmaceutical industry requires the strictest adherence to these principles because improper stock rotation may result in:

  • Product quality degradation due to expired or near-expiry materials
  • Increased risk of defects or contamination impacting patient safety
  • Regulatory non-compliance with consequences including warning letters, recalls, or suspension

Implementing FIFO and FEFO correctly is thus vital for maintaining material integrity, minimizing waste, and ensuring compliance with GMP regulations.

Also Read:  Coating Process Controls for Uniform and Defect-Free Tablets

Step 1: Mapping Your Inventory and Warehouse Layout for FIFO and FEFO Optimization

An initial and critical step in effective implementation is to thoroughly map your pharmaceutical warehouse’s inventory flow and layout. A well-designed warehouse layout aligned with FIFO and FEFO principles reduces mispicks and stock expiry risks.

Key Actions

  • Inventory Categorization: Classify materials by batch, manufacture date, and expiry date clearly. Group similar dosage forms and pack sizes to minimize confusion.
  • Visibility of Expiry Dates and Receipt Dates: Utilize barcode or RFID labeling that includes expiry and receipt dates prominently on each unit and pallet.
  • Logical Storage Zones: Designate specific storage zones based on expiry dates with clearly marked labels and signage. For instance, segregate near-expiry stock for prioritized picking.
  • Material Flow Direction: Configure racks and shelving to support natural first-in/first-out movement, enabling physical rotation of stock without complex handling.

Poor warehouse design and unclear labeling are root causes of common mistakes such as mispicks or inadvertent dispensing of expired stock. Regulators expect visible and accessible systems to ensure items close to expiry are identified and removed in a timely manner.

Document your warehouse layout and material flow in your procedures (e.g., Warehouse Management SOPs) referencing standards such as WHO’s GMP guidelines for storage to demonstrate compliance and control.

Step 2: Implementing Standard Operating Procedures (SOPs) for FIFO and FEFO

Effective implementation requires robust and tailored SOPs covering all aspects of storage, stock rotation, picking, and record-keeping. SOPs should clearly delineate responsibilities and methods underpinning FIFO and FEFO practices.

Common Mistakes in SOPs Include:

  • Ambiguous instructions on how to determine the sequence of issue leading to inconsistent application
  • Lack of integration with electronic Warehouse Management Systems (WMS) or manual stock control methods
  • Insufficient guidance on handling exceptions such as quarantined or rejected stock
  • Failure to address physical handling controls preventing mixing of batches with different expiry dates

Step-By-Step Guide to SOP Development and Training:

  1. Define Clear FIFO and FEFO Principles: Emphasize that FEFO takes precedence for regulated pharmaceutical products due to patient safety concerns.
  2. Detail Documentation Requirements: Specify how to record receipt dates, expiry dates, and batch identifiers accurately into the inventory system.
  3. Describe Stock Rotation Methods: Include how to perform physical stock movement on shelves, emphasizing front-loading with near-expiry stock for FEFO.
  4. Outline Picking Procedures: Define how material handlers verify expiry before selection to avoid mispicks.
  5. Integrate Exception Handling: SOP must clarify handling of quarantined, returned, or defective materials to prevent uninformed stock rotation errors.
  6. Train Personnel Regularly: Conduct hands-on training sessions and competency assessments for warehouse staff, warehouse supervisors, and QA oversight.
Also Read:  Warehouse SOP Template for FIFO and FEFO-Based Material Handling

Periodic SOP review and updates are mandatory, especially following deviations or audit findings related to stock expiry or mispicks.

Step 3: Leveraging Technology to Support FIFO and FEFO Compliance

Manual systems inherently carry a higher risk of mistakes such as overlooking expiration dates or incorrectly rotating stock. Pharmaceutical warehouses benefit significantly from electronic systems and automation to support FIFO and FEFO.

Recommended Technology Solutions:

  • Warehouse Management Systems (WMS): Integrated software that tracks batch numbers, manufacture and expiry dates, manages bin locations, and generates pick lists prioritizing FEFO issuance.
  • Barcode and RFID Scanning: Enables real-time inventory verification and prevents mispicks by cross-checking scanned labels against WMS data.
  • Automated Alerts and Reports: Configure the system to generate alerts for stock approaching expiration to trigger expedited picking or review.
  • Electronic Batch Records and Audit Trails: Ensure full traceability of stock movements and picking actions aligned with regulatory expectations for documentation integrity.

Without leveraging technology, even well-trained personnel can inadvertently commit mistakes such as issuing incorrect batches or overlooking expiry data. Technology acts both as a control mechanism and evidence during inspections and audits.

Guidance from agencies such as the FDA in their 21 CFR Part 211 outlines requirements for documentation and control systems which modern WMS solutions are designed to comply with.

Step 4: Conducting Regular Audits and Monitoring to Identify and Correct Mistakes

Proactive monitoring and auditing are fundamental to identifying errors like expired stock presence or recurrent mispicks. A systematic inspection process helps maintain continuous compliance with FIFO and FEFO requirements.

Audit and Monitoring Best Practices:

  • Scheduled Physical Inventory Checks: Regularly count and inspect stock for expiry dates matching the WMS records to detect discrepancies early.
  • Random Sampling Inspections: Select pallets randomly and verify correct stock rotation, documentation completeness, and labeling accuracy.
  • Traceability Exercises: Track selected batches from receipt to picking and dispatch, ensuring FIFO and FEFO principles were correctly applied.
  • Deviation Investigations: Thoroughly investigate any mispicks or expired stock incidents to identify root causes and implement corrective actions.
  • Key Performance Indicators (KPIs): Monitor metrics such as expiry-related stock losses, picking accuracy rate, and order turnaround times to assess process effectiveness.
Also Read:  FIFO and FEFO in Pharmaceutical Warehouses: Why Both Matter

Maintaining detailed records of audit findings and corrective/preventive actions (CAPAs) is essential for demonstrating compliance during regulatory inspections. MHRA and EMA guidelines emphasize that proper oversight controls reduce the risk of stock expiry and mispicks significantly.

Step 5: Implementing Training and Continuous Improvement Programs to Minimize Mistakes

Human factors play a decisive role in the effectiveness of FIFO and FEFO execution. Even the best systems can fail without well-trained, knowledgeable personnel. Continuous training and process improvement are therefore indispensable.

Key Components of Effective Training and Improvement:

  • Initial and Refresher Training: Comprehensive training on GMP principles, warehouse procedures, and system use for all warehouse staff, QA, and supply chain personnel.
  • Competency Assessment: Conduct tests or practical evaluations to confirm understanding and ability to perform FIFO and FEFO tasks correctly.
  • Feedback Channels: Establish mechanisms for operators to report issues or suggest improvements related to stock rotation and picking.
  • Review and Update Training Materials: Modify training content based on audit findings, technological upgrades, or procedural changes.
  • Process Improvement Teams: Utilize cross-functional teams including QA, production, and warehousing to analyze errors such as frequent mispicks or premature expiry and develop solutions.

Engaging staff in continuous improvement creates a culture of quality and vigilance that directly reduces impactful mistakes. Regular communication from management reinforces the critical importance of FIFO and FEFO compliance in product safety and regulatory adherence.

Summary: Key Takeaways to Avoid Mistakes in FIFO and FEFO Application

Pharmaceutical warehouses in the US, UK, and EU operate under stringent regulatory requirements mandating strict inventory control to prevent stock expiry and mispicks. Applying fifo and fefo in pharmaceutical warehouses effectively requires a holistic approach encompassing physical warehouse design, comprehensive SOPs, robust technology, vigilant auditing, and targeted personnel training.

Primary Mistakes to Avoid Include:

  • Inadequate warehouse layout leading to difficult stock rotation and visual misidentification
  • Poorly written or outdated procedures lacking clarity on expiry management and exception handling
  • Manual handling without electronic controls resulting in human errors such as mispicks
  • Insufficient monitoring and audit activities delaying correction of inventory inaccuracies
  • Neglecting ongoing staff training and ignoring feedback loops that curb repeated errors

By implementing the step-by-step framework outlined in this tutorial, pharmaceutical supply chain professionals can sustainably ensure compliance, maximize stock utilization, and protect patient safety. For further detailed guidance and pharmaceutical GMP standards, consult the WHO GMP guidelines and PIC/S documents explicitly addressing storage and distribution controls.

FIFO & FEFO Tags:errors, expiry, fefo, fifo, pharmagmp

Post navigation

Previous Post: Warehouse SOP Template for FIFO and FEFO-Based Material Handling
Next Post: How to Implement FIFO and FEFO in Warehouse Management Systems

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme